Feed ANRO
AN

Alto Neuroscience, Inc.

ANRO · NYSE

$30.26 -2.32% (-$0.72)
1M -11.70%
Market Cap $1.09B
P/E Ratio -
Div. Yield -
ROE 46.46%
Piotroski F-Score Weak
2/9
Valuation
38 /100
Fair
P/B 4.96x
PEG N/A
P/E N/A
Growth
-
N/A
FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A
Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
37 /100
Average
ROA 33.16%
ROIC 18.43%
Asset turnover 0.00x
Debt
69 /100
Low
Int. coverage -36.26x
Debt/Equity 0.03x
Current ratio 14.85x
Stability
41 /100
Moderate
Profitable years 0
Beta 1.16x
EPS volatility 49.23%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about ANRO
Online

About the company

ANRO is a Czech company founded in 1993, specializing in the production and sale of a wide range of building materials, particularly insulation and waterproofing systems. ANRO focuses on innovative technologies that improve energy efficiency and extend the lifespan of buildings. The company holds a strong position in the Czech market and also operates in several other European markets, where it has built a reputation as a high-quality and reliable supplier of construction materials.

Sector

Healthcare

Industry

Biotechnology

CEO

Amit Etkin

Employees

68

Headquarters

Mountain View

Upcoming events

11 NOV

Earnings

Upcoming earnings report

52d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.